Media Centre
Maidenhead, UK, 1st February, 2012 – The National Rheumatoid Arthritis Society (NRAS) is one of over 76 organisations to sign a joint letter in The Guardian asking the Government to support a cross-party amendment in the Welfare Reform Bill to exempt families with one additional unoccupied bedroom from having their Housing Benefit cut.
Click here to read more.
Maidenhead, UK, 23rd January 2012 - NRAS is one of nearly 30 organisations to sign an open letter in The Guardian urging the Government to reform the social care system.
Click here to read more.
Maidenhead, UK, 9th January 2012 - NRAS is one of over 40 organisations to sign an open letter in The Times urging the Government to strengthen the Health and Social Care Bill’s wording around service user involvement
Click here to read more.
Maidenhead, UK – 3rd January 2012- In an open letter published in The Telegraph today NRAS have joined with over 60 other signatories in urging the Prime Minister to work with other party leaders to take urgent action to reform social care for disabled and older people.
Click here to read more.
Maidenhead, UK – 14 December 2011 -The National Institute for Health and Clinical Excellence (NICE) has today issued final guidance for RoActemra® (Tocilizumab) for treating systemic juvenile idiopathic arthritis (sJIA) in children and young people aged 2 years and older, whose disease has responded inadequately to non-steroidal anti-inflammatory drugs (NSAIDS), systemic corticosteroids and methotrexate.
Click here to read more.
Maidenhead, UK – 24 November 2011 - NRAS today welcomes the publication
of Professor Harrington’s second independent review on the Work
Capability Assessment in 2011, which focuses on issues including:
• Introducing checks on benefit decisions to ensure fairness and consistency.
• Working with disability groups to help develop guidance for Atos healthcare professionals and decision makers.
• Improved support and communications for people who move onto
Jobseeker’s Allowance to make sure they get the help they need.
• Regularly publishing data on performance and quality to improve the transparency of the face-to face assessment.
Click here to read more.
Maidenhead, UK, 01 November, 2011 - The National Rheumatoid Arthritis
Society (NRAS) is delighted to announce the 10 winners of their third
Healthcare Champions Award in a year of celebrating their 10th
Anniversary. The winners, from around the UK, will be honoured at a
special reception to be held tonight at the State Rooms, Speaker’s
House, House of Commons, where the awards will be presented by The Home
Secretary and NRAS patron, The Rt Hon Theresa May MP. Click here to read more.
To mark World Arthritis Day, NRAS published new research on access to RA-related physiotherapy and held a live ministerial webchat with Paul Burstow MP. Please find the full webchat
here.
The National Rheumatoid Arthritis Society (NRAS) and the Chartered Society of Physiotherapy (CSP) today (12 October) publish a new UK-wide report highlighting the medical evidence around the benefits of physiotherapy in the treatment of Rheumatoid Arthritis (RA), but also uncovering serious problems in the way physiotherapy services are being organised and accessed throughout the UK.
Click here to read more on this report.
NRAS and the Chartered Society of Physiotherapy (CSP) are delighted to announce that Health Minister, Paul Burstow MP, has agreed to take part in a live webchat to mark this year’s World Arthritis Day on 12 October.
Click here to read the Health Minister's statement about the forthcoming webchat.
NRAS recently made a submission to Professor Harrington as part of his second review into the operation of the Work Capability Assessment. The submission focused on the issue of the quality of the Evidence Based Protocol on Rheumatoid Arthritis that is used by Atos Assessors to carry out medical assessments. We raised serious concerns about errors and omissions contained in the latest protocol relating to the characteristics, signs and symptoms of RA, and the treatment and prognosis for the disease.
For more information, please
click here.
WHAT: Disabled people, their families and friends taking to the streets in cities across the UK protesting against Government cuts to disability benefits and services. This takes place one year on from the Comprehensive Spending Review that revealed the Government’s intention to slash public spending.
WHEN: 22 October 2011
WHERE: Protests are planned across the UK, including Edinburgh, Cardiff, Leeds, Nottingham, Brighton, Manchester, Newcastle and Bristol (more locations to follow).
For more information, please
click here.
Maidenhead, UK, 07 September 2011 - NRAS is part of the Disability Benefits Consortium (DBC) of over fifty charities and other organisations committed to working towards a fair benefits system. The group has made a new joint submission to the Work and Pensions Select Committee as part of its inquiry into the future of the Disability Living Allowance (DLA) and the Personal Independence Payment (PIP). PIP is a new benefit for disabled people intended to replace DLA, which was announced in the consultation paper on Disability Living Allowance Reform in December 2010 and the Welfare Reform Bill, introduced in February 2011.
For more information, please
click here.
15th August 2011
The National Rheumatoid Arthritis Society is working in partnership with Arthritis Research UK (AR UK) to ensure the views of people with Rheumatoid Arthritis are represented within the Government’ new Personal Health Budgets initiative, which is currently being piloted in some parts of England.
More...
26th July 2011
The Work and Pensions Select Committee has today published its report on The role of incapacity benefit reassessment in helping claimants into employment. Reacting to the publication of the report, Ailsa Bosworth, Chief Executive of the National Rheumatoid Arthritis Society,
said...
23rd June 2011
NICE rejects use of abatacept following treatment failure with DMARDS, shutting the door for some patients with Rheumatoid Arthritis (RA) who are unable to take anti-TNF therapy, an alternative clinically effective treatment option.
More...
22nd June 2011
In final guidance, published today (22 June), the National Institute for Health and Clinical Excellence (NICE) recommends golimumab (Simponi) as an option for treating rheumatoid arthritis in specific circumstances where previous treatments haven't worked.
More...
7th June 2011
NRAS is part of the Disability Benefits Consortium (DBC) of over fifty charities and other organisations committed to working towards a fair benefits system. Yesterday the group made a joint submission to the Department for Work and Pensions as its consultation on the initial draft criteria for the Personal Independence Payment assessment (PIP) came to a close.
More...
27th May 2011
NRAS is one of forty charities and coalitions to have come together today to release the 'Listen Up' statement, calling for changes to the Health and Social Care Bill.
More...
13th May 2011
Recommendation of the First Monthly Subcutaneous Injection for use after Treatment Failure with DMARDs Provides More Options for Rheumatoid Arthritis (RA) Patients.
More...
The current NICE clinical guidelines offer best practice advice on the care of adults with RA based on the best available evidence. The recent National Audit Office Report highlights that there is a variation in the implementation of NICE guidelines in the NHS.
More...
The Chancellor of the Exchequer, George Osborne, yesterday delivered his second Budget, which set out further measures intended to tackle deficit reduction and promote growth in the UK economy.
More...
On Wednesday 25th August, NICE issued final guidance on Tocilizumab. The Guidance states that Tocilizumab, (RoActemra) in combination with methotrexate, is recommended for the treatment of moderate to severe active rheumatoid arthritis
More...
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor.
More...
New research presented at the British Society of Rheumatology (BSR) annual conference in Birmingham during April 2010 has confirmed what has been known anecdotally through clinical experience.
More...
The largest ever survey of rheumatoid arthritis (RA) patients of working age in Scotland has revealed that the severe fatigue caused by the disease is the largest barrier to people staying in employment, with over 80% citing it as a factor.
More...